Ligand Pharmaceuticals (LGND) Exchange Rate Effect (2018 - 2026)
Ligand Pharmaceuticals (LGND) reported Exchange Rate Effect of -$44000.0 for Q1 2026, down 104.16% on a YoY basis from $1.1 million in Q1 2025, and up 92.54% sequentially from -$590000.0 in Q4 2025.
Ligand Pharmaceuticals (LGND) Exchange Rate Effect (2018 - 2026) Analysis & Trends
Ligand Pharmaceuticals (LGND) has 6 years of Exchange Rate Effect data on file, last reported at -$44000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 104.16% year-over-year to -$44000.0; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 1213.27% YoY), and the FY2025 full-year result was $2.4 million, up 301.54% from the prior year.
- Exchange Rate Effect advanced to -$44000.0 in Q1 2026, from -$590000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $5.2 million in Q3 2024 to a low of -$4.8 million in Q2 2024.
- A 3-year average of $143125.0 and a median of -$222000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 147.6% in 2025, while the deepest fall reached 107.7% in 2025.
- Tracing LGND's Exchange Rate Effect over 3 years: stood at -$1.5 million in 2024, then jumped by 61.89% to -$590000.0 in 2025, then jumped by 92.54% to -$44000.0 in 2026.
- Business Quant data shows LGND's Exchange Rate Effect at -$44000.0 in Q1 2026, -$590000.0 in Q4 2025, and -$400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ligand Pharmaceuticals | 6.05 Bn | 5.27 Bn | 48.45 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44,000.00 |
| Mar 31, 2026 | -44,000.00 |
| Dec 31, 2025 | -590,000.00 |
| Dec 31, 2025 | -590,000.00 |
| Sep 30, 2025 | -400,000.00 |
| Sep 30, 2025 | -400,000.00 |
| Jun 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | -1.55 Mn |
| Dec 31, 2024 | -1.55 Mn |
| Sep 30, 2024 | 5.19 Mn |
| Sep 30, 2024 | 5.19 Mn |
| Jun 30, 2024 | -4.82 Mn |
| Jun 30, 2024 | -4.82 Mn |
| Dec 31, 2020 | 50,000.00 |
| Dec 31, 2020 | 50,000.00 |
| Sep 30, 2020 | 110,000.00 |
| Sep 30, 2020 | 110,000.00 |